@article{7e6f1c4561ef4c1886ae1bd25dd608b7,
title = "Impact of “psychosis risk” identification: Examining predictors of how youth view themselves",
abstract = "Background: Identifying young people as at clinical high-risk (CHR) for psychosis affords opportunities for intervention to possibly prevent psychosis onset. Yet such CHR identification could plausibly increase stigma. We do not know whether these youth already perceive themselves to be at psychosis-risk (PR) or how their being told they are at PR might impact how they think about themselves. Methods: 148 CHR youth were asked about labels they had been given by others (labeling by others) or with which they personally identified (self-labeling). They were then asked which had the greatest impact on how they thought about themselves. We evaluated whether being told vs. thinking they were at PR had stronger effects. Findings: The majority identified nonpsychotic disorders rather than PR labels as having the greatest impact on sense of self (67.6% vs. 27.7%). However, participants who identified themselves as at PR had an 8.8 (95% CI = 2.0-39.1) increase in the odds of the PR label having the greatest impact (p < 0.01). Additionally, having been told by others that they were at PR was associated with a 4.0 increase in odds (95% CI = 1.1-15.0) that the PR label had the most impact (p < 0.05). Interpretation: Nonpsychotic disorder labels appear to have a greater impact on CHR youth than psychosis-risk labels. However, thinking they are at PR, and, secondarily, being told they are at PR, appears to increase the relative impact of the PR label. Understanding self- and other-labeling may be important to how young people think of themselves, and may inform early intervention strategies.",
keywords = "Clinical high risk state for psychosis, Early intervention, Identity, Psychosis risk, Stigma",
author = "Yang, {Lawrence H.} and Woodberry, {Kristen A.} and Link, {Bruce G.} and Corcoran, {Cheryl M.} and Caitlin Bryant and Shapiro, {Daniel I.} and Donna Downing and Girgis, {Ragy R.} and Gary Brucato and Debbie Huang and Crump, {Francesca M.} and Mary Verdi and McFarlane, {William R.} and Seidman, {Larry J.}",
note = "Funding Information: The authors have declared that there are no conflicts of interest in relation to the subject of this study. We declare that no authors have support from any company for the submitted work. Dr. Yang was supported by funds from NIMH R01-MH096027 (PI: Yang), entitled “Stigma Associated with a High-Risk State for Psychosis”, and a Brain and Behavior Foundation Young Investigator Award (NARSAD 17839). Dr. Corcoran was supported by funds from NIMH R01MH107558. Dr. Shapiro reports grants from NIMH (under Dr. Larry Seidman, site PI at BIDMC) during the conduct of the study; Debbie Huang was supported by the NIMH training grant T32 MH013043 regarding psychiatry epidemiology; During the 36 months prior to submission, Dr. Woodberry was supported by funds from NIH (R01 MH096027;R21 MH093294;U01 MH081928; R01 MH101052; K23 MH102358), the Massachusetts Department of Mental Health (“Training for Early Intervention in Psychosis” and SCDMH82101008006), and the Sidney R. Baer, Jr. Foundation. Dr. Girgis reports non-financial support from Genentech, grants from Otsuka, non-financial support from Bioadvantex, grants from Allergan, outside the submitted work. Dr. McFarlane was supported by funds from the Maine Medical Center Research Institute. Funding: NIMH R01-MH096027 (PI:Yang). Funding Information: The authors have declared that there are no conflicts of interest in relation to the subject of this study. We declare that no authors have support from any company for the submitted work. Dr. Yang was supported by funds from NIMH R01-MH096027 (PI: Yang), entitled “Stigma Associated with a High-Risk State for Psychosis”, and a Brain and Behavior Foundation Young Investigator Award ( NARSAD 17839 ). Dr. Corcoran was supported by funds from NIMH R01MH107558 . Dr. Shapiro reports grants from NIMH (under Dr. Larry Seidman, site PI at BIDMC) during the conduct of the study; Debbie Huang was supported by the NIMH training grant T32 MH013043 regarding psychiatry epidemiology; During the 36 months prior to submission, Dr. Woodberry was supported by funds from NIH ( R01 MH096027 ; R21 MH093294 ; U01 MH081928 ; R01 MH101052 ; K23 MH102358 ), the Massachusetts Department of Mental Health (“Training for Early Intervention in Psychosis” and SCDMH82101008006), and the Sidney R. Baer, Jr. Foundation. Dr. Girgis reports non-financial support from Genentech, grants from Otsuka, non-financial support from Bioadvantex, grants from Allergan, outside the submitted work. Dr. McFarlane was supported by funds from the Maine Medical Center Research Institute . Publisher Copyright: {\textcopyright} 2019 Elsevier B.V.",
year = "2019",
month = jun,
doi = "10.1016/j.schres.2019.01.037",
language = "English (US)",
volume = "208",
pages = "300--307",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
}